DiagnaMed Holdings CorpGrey Market:DGNMFView on Canadian Exchange
- LAST PRICE0.0127
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0040/ 100
- Ask / Lots0.0768/ 100
- Open / Previous Close--- / 0.0127
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DGNMF |
|---|
Nov 14, 2024
DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement, from 5:45PM ET on Wednesday Nov 13, 2024 by Dow Jones
5:45PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 7, 2024
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Oct 30, 2024
DiagnaMed Advancing the Medical Potential of Hydrogen, from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
DiagnaMed Holdings Corp | 1.6M | --- | --- |
Company Information
DiagnaMed Holdings Corp. is a Canada-based healthcare technology company focused on brain health using artificial intelligence (AI). The Company is commercializing BRAIN AGE Brain Health AI Platform, a consumer brain health and wellness AI solution that estimates brain age and provides a brain health score. The BRAIN AGE Brain Health AI Platform (BRAIN AGE) leverages its electroencephalograph (EEG) data from research studies and future data collection and applying it to build a potential drug discovery and clinical research AI platform. The BRAIN AGE estimates brain age by recording brain-wave activity from multiple brain regions and calculating the data with a proprietary machine-learning model. The BRAIN AGE has the potential to accelerate patient recruitment for clinical trials, data analysis, drug development go/no-go decisions and new treatment options for neurological, psychiatric and infectious diseases.
Contact Information
- Headquarters
- Suite 2900, 550 Burrard StreetVANCOUVER, BC, Canada V6C 0A3
- Phone
- 778-683-4324
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 81.4M |
DiagnaMed Holdings Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.01 |
Book Value | $0.00 |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
